Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Gynecology

Free Subscription 27.04.2026 3 Acta Obstet Gynecol Scand 6 Am J Obstet Gynecol 6 BMC Cancer 1 Br J Radiol 2 Clin Cancer Res 1 Diagn Cytopathol 11 Eur J Obstet Gynecol Reprod Biol 6 Gynecol Endocrinol 13 Gynecol Oncol 2 Hum Reprod 4 Int J Cancer 7 Int J Gynaecol Obstet 1 Int J Radiat Oncol Biol Phys 2 J Clin Endocrinol Metab 5 JAMA 1 Lancet 3 Obstet Gynecol 1 Oncogene 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. LIU S, Li L, Wu P, Wang L, et al
   Fat reduction mediates the efficacy of intensive lifestyle interventions on fertility-sparing treatment in overweight patients with endometrial cancer and intraepithelial neoplasia.
   Acta Obstet Gynecol Scand. 2026 Apr 22. doi: 10.1111/aogs.70231.
   PubMed         Abstract available
   
   
2. DOWTHWAITE S, Quinton A, Thomas S, Schlub T, et al
   Further consideration of long-term outcomes, utilization decisions, and surgical technique could inform clinical guidelines for ultrasound guided uterine evacuation.
   Acta Obstet Gynecol Scand. 2026 Apr 22. doi: 10.1111/aogs.70237.
   PubMed        
   
   
3. HOLOPAINEN LS, Tahtinen HH, Gissler M, Korhonen PE, et al
   Maternal smoking during pregnancy and gestational diabetes mellitus: Interactions and independent associations on pregnancy duration and perinatal outcomes.
   Acta Obstet Gynecol Scand. 2026 Apr 21. doi: 10.1111/aogs.70233.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

4. LARSEN ML, Kristensen SE, Rasmussen MK, Hoei-Hansen CE, et al
   Neurodevelopmental Disorders Following Fetal Reduction of Triplet Pregnancies: A Nationwide Cohort Study.
   Am J Obstet Gynecol. 2026 Apr 16:S0002-9378(26)00202.
   PubMed         Abstract available
   
   
5. GRUNEBAUM A, Coverdale JH, Gordon MR, McLeod-Sordjan R, et al
   Improving Communication in Pregnancy: A Neurodivergent-Responsive Approach.
   Am J Obstet Gynecol. 2026 Apr 17:S0002-9378(26)00205.
   PubMed        
   
   
6. SCHAFFER AC, Einbinder JS, Zawi T, Sato L, et al
   The Role of Language Barriers in Medical Professional Liability Cases in Obstetrics and Gynecology.
   Am J Obstet Gynecol. 2026 Apr 17:S0002-9378(26)00206.
   PubMed        
   
   
7. RAJKUMAR T, Hennessy A, Shanmugalingam R, You W, et al
   A randomized controlled trial comparing remote blood pressure monitoring with office-based blood pressure monitoring for women at high risk of preeclampsia.
   Am J Obstet Gynecol. 2026 Apr 21:S0002-9378(26)00210.
   PubMed         Abstract available
   
   
8. PELLETIER F, Gallais Serezal I, Puyraveau M, Leroux F, et al
   Electromyography-guided botulinum toxin injections in provoked vestibulodynia: a randomized double-blind placebo-controlled clinical trial.
   Am J Obstet Gynecol. 2026;234:1362-1369.
   PubMed         Abstract available
   
   
9. ADAMS PE, Vikram EP, Curman P, Kraus CN, et al
   Topical therapy and vulvar malignancy risk in lichen sclerosus: a large propensity-matched study.
   Am J Obstet Gynecol. 2026;234:1402-1415.
   PubMed         Abstract available
   
   

   
   BMC Cancer

10. ZHOU X, Xu H, Fu Y, Nie Q, et al
    Geographic and demographic patterns of cervical cancer in Africa using GLOBOCAN 2022.
    BMC Cancer. 2026 Apr 18. doi: 10.1186/s12885-026-16000.
    PubMed        
    
    
11. LIU X, Liao Y, Liu Y, Huang H, et al
    Molecular markers for cervical cancer prognosis: a prognostic model using stemness-related lncRNAs and functional analysis of EMX2OS.
    BMC Cancer. 2026 Apr 20. doi: 10.1186/s12885-026-16022.
    PubMed        
    
    
12. TROJNARSKA D, Trzeszcz M, Stukan M, Mazurec K, et al
    HPV vaccination beyond primary prevention: survey of practices and attitudes of Polish obstetrician-gynecologists.
    BMC Cancer. 2026 Apr 22. doi: 10.1186/s12885-026-15974.
    PubMed        
    
    
13. HUANG S, Wu S, Li Y, Lin Y, et al
    The value of tertiary lymphoid structure on predicting the survival rate of advanced cervical cancer patients.
    BMC Cancer. 2026 Apr 23. doi: 10.1186/s12885-026-16019.
    PubMed        
    
    
14. ZHANG Y, Dai T, Chu D, Zhang W, et al
    Extracellular vesicles derived from ovarian cancer cells promote tumor progression through m2 macrophage polarization and enhanced angiogenesis.
    BMC Cancer. 2026 Apr 24. doi: 10.1186/s12885-026-16059.
    PubMed        
    
    
15. NYABYENDA EC, Nkurikiyeyezu K, Sylvain MH, Absolomon G, et al
    Image analysis for cervical cancer classification using deep learning techniques.
    BMC Cancer. 2026 Apr 23. doi: 10.1186/s12885-026-16076.
    PubMed        
    
    

    
    Br J Radiol

16. GU Y, Zhao L, Yang L, Zhang Z, et al
    A diagnostic nomogram model integrating the Ultrasound Ovarian-Adnexal Reporting and Data System and serum indexes for predicting malignancy in patients with ovarian masses.
    Br J Radiol. 2026 Apr 22:tqag084. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

17. FUNK AM, Brieske M, Schwarz FM, Link T, et al
    A urinary three-metabolite signature enables non-invasive identification of high-risk ovarian cancer patients.
    Clin Cancer Res. 2026 Apr 24. doi: 10.1158/1078-0432.CCR-25-4260.
    PubMed         Abstract available
    
    
18. SACHDEVA M, Tan DSP
    Returning to PARP inhibition: Rechallenge with Bevacizumab in Ovarian Cancer.
    Clin Cancer Res. 2026 Apr 23. doi: 10.1158/1078-0432.CCR-26-0534.
    PubMed         Abstract available
    
    

    
    Diagn Cytopathol

19. OLSON K, Kucher E, Rasmussen A, Selvaggi SM, et al
    Unsatisfactory ThinPrep Pap Tests: An Educational Approach to Quality.
    Diagn Cytopathol. 2026;54:444-448.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

20. TANDULWADKAR S, Mukherjee B, Ganpule C, Patel M, et al
    Expert opinion by Federation of Obstetric and Gynaecological Societies of India on elagolix - Redefining the endometriosis therapy landscape.
    Eur J Obstet Gynecol Reprod Biol. 2026;322:115115.
    PubMed         Abstract available
    
    
21. LAMY C, Rozenberg P, Boulvain M
    Obstetric challenges in suspected fetal macrosomia: Risk factors and assessment.
    Eur J Obstet Gynecol Reprod Biol. 2026;322:115120.
    PubMed         Abstract available
    
    
22. STEELMAN M, Fox NS
    Hematologic profiles in twin vs. singleton pregnancies across gestation.
    Eur J Obstet Gynecol Reprod Biol. 2026;322:115128.
    PubMed         Abstract available
    
    
23. STROBEL L, Gleirscher N, Hofbauer F, Emmelheinz M, et al
    Long-Term outcomes after endometrial Ablation: A case series at the medical University Innsbruck.
    Eur J Obstet Gynecol Reprod Biol. 2026;322:115127.
    PubMed         Abstract available
    
    
24. HSU JZ, Ding DC
    Impact of different prophylactic antibiotics regimens on the risk of urinary tract infections after hysterectomies due to benign Indications: A retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2026;322:115123.
    PubMed         Abstract available
    
    
25. VAN DEN BERG LMM, Gordon BBM, van Dillen J, Henrichs J, et al
    Perinatal outcomes and care patterns after centralisation of acute obstetric care in three Dutch regions: a retrospective cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2026;322:115105.
    PubMed         Abstract available
    
    
26. STALBERG K, Magnusson J, Jonsdottir B
    The role of CT scans in endometrial cancer diagnosis: tumor spread and incidental findings.
    Eur J Obstet Gynecol Reprod Biol. 2026;322:115131.
    PubMed         Abstract available
    
    
27. SEALE L, Bates N, Tumin D, Sutton J, et al
    The association between age at menarche and polycystic ovary syndrome among reproductive-aged women in the US.
    Eur J Obstet Gynecol Reprod Biol. 2026;322:115140.
    PubMed         Abstract available
    
    
28. VUPPU DP, Bhati P, Nair IR, Anusree K, et al
    Visual assessment of residual peritoneal disease during interval cytoreductive surgery: a prospective comparison of gross visualisation and laparoscope-assisted techniques.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115034.
    PubMed         Abstract available
    
    
29. PACHECO VIEIRA LL, Suruagy-Motta RFO, Bomfim JQ, Dos Santos Teixeira AL, et al
    The efficacy of male partner treatment to prevent recurrence of bacterial Vaginosis: A systematic review with Meta-Analysis of randomized controlled trials.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115047.
    PubMed         Abstract available
    
    
30. MARYNS AS, Hamerlynck T, van Overberghe C, Allaert E, et al
    Opportunistic salpingectomy: Is surgical completeness achieved? Insights from the QOS study.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115066.
    PubMed         Abstract available
    
    

    
    Gynecol Endocrinol

31. AKSU E, Erbas O
    Alpha-lipoic acid preserves uterine and ovarian integrity in streptozotocin-induced diabetic rats via modulation of TGF-beta and HSP70 pathways.
    Gynecol Endocrinol. 2026;42:2660420.
    PubMed         Abstract available
    
    
32. MI H, Zhao L, Guo J
    Identification of key genes in recurrent pregnancy loss related to obesity.
    Gynecol Endocrinol. 2026;42:2659978.
    PubMed         Abstract available
    
    
33. SAPONARA S, D'Alterio MN, Di Michele S, Chila C, et al
    Relugolix combination therapy in symptomatic adenomyosis and uterine fibroids: a case series.
    Gynecol Endocrinol. 2026;42:2659439.
    PubMed         Abstract available
    
    
34. FERREIRA B, Robin G, Pigny P, Bachelot A, et al
    Is a systematic adrenocorticotropic hormone (ACTH) stimulation test useful in diagnosing nonclassical congenital adrenal hyperplasia (NCAH)?
    Gynecol Endocrinol. 2026;42:2659979.
    PubMed         Abstract available
    
    
35. KARAKELLEOGLU G, Karadag C
    Dysregulated endometrial podocalyxin and LIF expression in women with ovarian endometrioma.
    Gynecol Endocrinol. 2026;42:2662696.
    PubMed         Abstract available
    
    
36. DELL'AQUILA M, Della Corte L, Kafetzis D, Bifulco G, et al
    Continuous estetrol/drospirenone regimen for the treatment of endometriosis-related pain: preliminary results.
    Gynecol Endocrinol. 2026;42:2662694.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

37. 
    Society of Gynecologic Oncology Annual Meeting Special Issue.
    Gynecol Oncol. 2026;207S:1.
    PubMed        
    
    
38. LIU JB, He TX, Zeng C, Kaur MN, et al
    Association of surgical complexity with patient-reported outcomes among patients with ovarian cancer.
    Gynecol Oncol. 2026;208:106-112.
    PubMed         Abstract available
    
    
39. KIM JH, Hwang WY, Choi CH, Kim HS, et al
    Oncologic outcomes and the impact of minimally invasive surgery in early-stage cervical cancer patients undergoing radical trachelectomy: A retrospective multicenter cohort study from the Korean Gynecologic Oncology Group Study (KGOG 1048).
    Gynecol Oncol. 2026;208:113-121.
    PubMed         Abstract available
    
    
40. OGASAWARA A, Suzuki S, Oda K, Yunokawa M, et al
    Phase II study of pembrolizumab plus olaparib in recurrent cervical cancer progressing after platinum-based chemotherapy (GOTIC-025).
    Gynecol Oncol. 2026;208:122-130.
    PubMed         Abstract available
    
    
41. LIU B, Chen J, Chen L, Chen X, et al
    Efficacy and safety of cadonilimab combined with chemotherapy as first-line treatment for primary advanced or recurrent endometrial cancer: An interim analysis of a prospective, single-arm, open-label phase II trial.
    Gynecol Oncol. 2026;207S:14-22.
    PubMed         Abstract available
    
    
42. HSIEH TYJ, Yen TT, Hacker MR, Dottino J, et al
    Impact of GLP-1 RA plus progestin therapy on fertility-sparing management of endometrial intraepithelial neoplasia and endometrial cancer.
    Gynecol Oncol. 2026;207S:23-29.
    PubMed         Abstract available
    
    
43. VAN NIEUWENHUYSEN E, Vergote I, Randall LM, Tromp J, et al
    Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study.
    Gynecol Oncol. 2026;207S:3-13.
    PubMed         Abstract available
    
    
44. SAWAYA K, Maraghe M, Metzger S, Heming CM, et al
    Identifying ovarian cancer with AI analysis of abdominal CT scans.
    Gynecol Oncol. 2026;207S:30-37.
    PubMed         Abstract available
    
    
45. EPSTEIN ES, Primiano M, Ozarowski AL, Karimaghaie T, et al
    ACT-ON: Assisted cascade testing via outreach and navigation - Real-world experience with clinician-facilitated cascade testing.
    Gynecol Oncol. 2026;207S:38-46.
    PubMed         Abstract available
    
    
46. ROTHNIE K, Tristano E, Diaz-Rodriguez M, Filippova O, et al
    Expanded subtype testing for circulating tumor HPV DNA reliably detects the presence of advanced-stage cervical cancer.
    Gynecol Oncol. 2026;207S:47-52.
    PubMed         Abstract available
    
    
47. KRIVENKO O, Diaz N, Richardson K, Antonio D, et al
    Impact of a community-centered intervention on knowledge, confidence, and attitudes toward clinical trials: A pilot survey study.
    Gynecol Oncol. 2026;207S:53-59.
    PubMed         Abstract available
    
    
48. LEVIN G, Gilbert L, Coleman RL, Meyer R, et al
    Industry payments to U.S. gynecologic oncologists: Gender, geographic, and therapeutic trends.
    Gynecol Oncol. 2026;207S:60-66.
    PubMed         Abstract available
    
    
49. BASHI A, Penvose KN, Wright JD, Blank SV, et al
    Cost and efficiency of universal versus selective next generation sequencing for advanced stage endometrial cancer.
    Gynecol Oncol. 2026;207S:67-73.
    PubMed         Abstract available
    
    

    
    Hum Reprod

50. MORBEY EJ, Day FR, Wright DJ, Murzynowski JRA, et al
    Large-scale analysis of FMR1 CGG repeat length and risk of premature ovarian insufficiency in over 92 000 women.
    Hum Reprod. 2026 Apr 19:deag061. doi: 10.1093.
    PubMed         Abstract available
    
    
51. BERLANDA N, Bandini V, Croci GA, Dridi D, et al
    Histological and immunohistochemical characteristics of superficial peritoneal endometriotic lesions of clinical responders and non-responders to dienogest treatment.
    Hum Reprod. 2026 Apr 18:deag059. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Cancer

52. SCHROLL JB, Bonde J, Lynge E, Waldstrom M, et al
    Health care policy trial of primary human papillomavirus-based cervical screening in Denmark: Comparison of three triage algorithms.
    Int J Cancer. 2026;158:3197-3207.
    PubMed         Abstract available
    
    
53. MONBERG TJ, Lorentzen CL, Westergaard MCW, Iversen TZ, et al
    Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian Cancer.
    Int J Cancer. 2026 Apr 23. doi: 10.1002/ijc.70510.
    PubMed         Abstract available
    
    
54. TANVEER FS, Saeed MH, Zaidi TH
    Comments on: "Enhanced Diagnostic Accuracy of High-Grade Cervical Intraepithelial Neoplasia in Postmenopausal Women Through PAX1/JAM3 Methylation Analysis".
    Int J Cancer. 2026 Apr 20. doi: 10.1002/ijc.70485.
    PubMed        
    
    
55. PENG H, Li J, Zhou Q, Zhou H, et al
    Reply to: Comments on "Enhanced Diagnostic Accuracy of High-Grade Cervical Intraepithelial Neoplasia in Postmenopausal Women Through PAX1/JAM3 Methylation Analysis".
    Int J Cancer. 2026 Apr 20. doi: 10.1002/ijc.70484.
    PubMed        
    
    

    
    Int J Gynaecol Obstet

56. DEMIRTOP H, Beydag KD, Karaahmet AY
    Development and validation of the gynecologic examination anxiety scale (GEAS): A 20-item patient-reported measure.
    Int J Gynaecol Obstet. 2026 Apr 20. doi: 10.1002/ijgo.71014.
    PubMed         Abstract available
    
    
57. AYGUN ARI D, Pehlivanturk Kizilkan M, Ozturk M, Ertugrul I, et al
    Subclinical cardiac alterations and cardiometabolic profile in adolescents with newly diagnosed polycystic ovary syndrome: A cross-sectional comparative echocardiographic study.
    Int J Gynaecol Obstet. 2026 Apr 20. doi: 10.1002/ijgo.71017.
    PubMed         Abstract available
    
    
58. TULANDI T, Mocanu E, Purandare N, Nelson SM, et al
    Response: Gynecologic surgery for benign disease: Preserving reproductive potential.
    Int J Gynaecol Obstet. 2026 Apr 20. doi: 10.1002/ijgo.71031.
    PubMed        
    
    
59. ZHANG V, Mantri D, Yang Q, Guan X, et al
    Indocyanine green for intraoperative ureteral identification in gynecologic surgery: A preliminary systematic review of feasibility, safety, and surgical outcomes.
    Int J Gynaecol Obstet. 2026 Apr 20. doi: 10.1002/ijgo.71025.
    PubMed         Abstract available
    
    
60. LEJEUNE C, Nanda S, Poon L, Amant F, et al
    Response: Cancer in pregnancy: FIGO Best practice advice and narrative review.
    Int J Gynaecol Obstet. 2026;173:1148-1149.
    PubMed        
    
    
61. SAVI AL, Lieber J, Raquel Teatin Juliato C, Scott R, et al
    Pain at intrauterine device placement in a Brazilian center.
    Int J Gynaecol Obstet. 2026 Apr 21. doi: 10.1002/ijgo.71026.
    PubMed         Abstract available
    
    
62. TANG X, Zhao P, Ying X, Fu D, et al
    Effectiveness of preoperative vaginal preparation in reducing post-operative infection in patients who underwent emergency cesarean delivery: A systemic review and meta-analysis.
    Int J Gynaecol Obstet. 2026;173:710-720.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

63. HOUDOU L, Bruand M, Laroze S, Annede P, et al
    UNICURE-HD: A Multicentric retrospective cohort study of Single-Insertion Image-Guided HDR Brachytherapy for Locally Advanced Cervical Cancer in the context of Limited Brachytherapy access in France.
    Int J Radiat Oncol Biol Phys. 2026 Apr 18:S0360-3016(26)00598.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

64. UNUANE D, Velkeniers B, Poppe KG
    Thyroid Disorders and Female Infertility.
    J Clin Endocrinol Metab. 2026 Feb 3:dgag039. doi: 10.1210.
    PubMed         Abstract available
    
    
65. WHOOTEN RC, Rifas-Shiman SL, Aris IM, Perng W, et al
    Adolescent "Lean PCOS" Is Characterized by Higher Insulin Resistance and Adverse Adipokine Profile.
    J Clin Endocrinol Metab. 2026;111:e1364-e1372.
    PubMed         Abstract available
    
    

    
    JAMA

66. MAYA J, Thaweethai T, Powe CE
    Gestational Weight Gain and Pregnancy Outcomes After Discontinuation of GLP-1 Receptor Agonists-Reply.
    JAMA. 2026 Apr 20. doi: 10.1001/jama.2026.2654.
    PubMed        
    
    
67. HNID K
    Gestational Weight Gain and Pregnancy Outcomes After Discontinuation of GLP-1 Receptor Agonists.
    JAMA. 2026 Apr 20. doi: 10.1001/jama.2026.2651.
    PubMed        
    
    
68. BOUJENAH J
    Gestational Weight Gain and Pregnancy Outcomes After Discontinuation of GLP-1 Receptor Agonists.
    JAMA. 2026 Apr 20. doi: 10.1001/jama.2026.2648.
    PubMed        
    
    
69. BOND RM, Debbink MP, Geller A, Lieu TA, et al
    Preventing Pregnancy-Related Cardiovascular Disease Burden: A Report From the National Academies of Sciences, Engineering, and Medicine.
    JAMA. 2026 Apr 21. doi: 10.1001/jama.2026.6717.
    PubMed        
    
    
70. HSWEN Y
    AI Drug Safety in Pregnancy.
    JAMA. 2026 Apr 23:e2524562. doi: 10.1001/jama.2025.24562.
    PubMed        
    
    

    
    Lancet

71. THE LANCET
    Abortion: the possibilities of progress.
    Lancet. 2026;407:1483.
    PubMed        
    
    

    
    Obstet Gynecol

72. VOSOONEY A, Witkop CT, Cantor AG, Nelson HD, et al
    Screening for Cervical Cancer: A Recommendation From the Women's Preventive Services Initiative.
    Obstet Gynecol. 2026 Apr 23. doi: 10.1097/AOG.0000000000006315.
    PubMed         Abstract available
    
    
73. ARCE MG, Montgomery A, Koo K, Koritsanszky L, et al
    Centering Reproductive and Migrant Justice: Dismantling Inequities in Newcomer Pregnancy Care.
    Obstet Gynecol. 2026 Apr 23. doi: 10.1097/AOG.0000000000006289.
    PubMed         Abstract available
    
    
74. 
    Screening for Cervical Cancer.
    Obstet Gynecol. 2026 Apr 24. doi: 10.1097/AOG.0000000000006257.
    PubMed         Abstract available
    
    

    
    Oncogene

75. WEI Y, Chen Z, Li Y, Song K, et al
    Correction: The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.
    Oncogene. 2026 Apr 23. doi: 10.1038/s41388-026-03810.
    PubMed        
    
    

    
    PLoS One

76. WHOP LJ, Mitchell LE, Butler TL, Wong D, et al
    Screen Your Way Study Protocol: Embedding community driven models to increase cervical screening via HPV self-collection to improve cervical cancer outcomes for Aboriginal and Torres Strait Islander people.
    PLoS One. 2026;21:e0336004.
    PubMed         Abstract available
    
    
77. MARCUS P, Warrington J, Zhang M, Ankathatti-Munegowda M, et al
    Intraperitoneal administration of NK-92 improves survival in xenografts of early and established ovarian cancer models.
    PLoS One. 2026;21:e0347095.
    PubMed         Abstract available
    
    
78. MOSCOSO A, Mohammad Mirzaei N, Shahriyari L
    Analysis of ovarian cancer immune cell profile identifies immunosuppressive states associated with adverse clinical attributes and survival times.
    PLoS One. 2026;21:e0346746.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum